Molecular Determinants of Mossy Fiber Presynaptic Channelopathies in Epilepsy
癫痫苔藓纤维突触前通道病的分子决定因素
基本信息
- 批准号:7289098
- 负责人:
- 金额:$ 25.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAgreementAntiepileptic AgentsApplications GrantsAreaAttenuatedAutoreceptorsAxonBrainCellsChromosome PairingChronicDNA Sequence RearrangementDataDepressed moodDevelopmentDiseaseDown-RegulationDyesEpilepsyEpileptogenesisExcisionFeedbackFiberFoundationsFunctional disorderFundingFutureGene MutationGeneticGlutamatesGoalsHandHippocampal Mossy FibersHippocampus (Brain)HumanImageryImmunoliposomeInheritedIon ChannelLinkLong-Term DepressionMediatingMessenger RNAMetabotropic Glutamate ReceptorsModelingMolecularMonitorMutateNeuronsNeurotransmitter ReceptorOperative Surgical ProceduresPathogenesisPathway interactionsPatientsPersonal SatisfactionPhenotypePlayPolymerase Chain ReactionPotassium ChannelProtease InhibitorPyramidal CellsRNA SplicingRattusRecurrenceReportingResearchRoleScoreSeizuresSynapsesTechniquesTemporal Lobe EpilepsyTestingTherapeutic InterventionTimeTissuesTranscriptVariantcell typedentate gyrusgene therapygranule cellinnovationlarge-conductance calcium-activated potassium channelsmetabotropic glutamate receptor 2mossy fibernerve supplyneuronal excitabilityneurotransmissionnovelnovel therapeuticspatch clamppostsynapticpresynapticreceptorresponsesynaptogenesistransmission process
项目摘要
DESCRIPTION (provided by applicant): Epilepsies are a diverse group of paroxysmal disorders that have been linked to genetic or acquired ion channel and/or neurotransmitter receptor dysfunctions, the so-called "channelopathies." The hippocampal mossy fibers undergo molecular and structural rearrangement in human and experimental mesial temporal lobe epilepsy (MTLE). Recent data revealed a robust down-regulation of both group II metabotropic glutamate receptors (mGluR II) and the large conductance Ca2+activated potassium channel (BK channels) in mossy fibers of epileptic rats. In the normal brain, "feedback" activation of presynaptic autoreceptor mGluR II in concert with other ion channels (i.e., BK channels) attenuates excessive excitatory transmission. Hence, presynaptic deficit in mGluR II and BK channels may play a major role in epileptogenesis. The specific aims of this project are: (1) to test the hypothesis that down-regulation of mGluR II and BK channels in mossy fiber of epileptic rats correlates with similar deficit in mRNA transcripts and abnormal expression of splice variants in granule cells; (2) to test the hypothesis that seizure-induced down-regulation of mGluR II and BK channels affects presynaptic function and exacerbates excitatory transmission at mossy fiber-CA3 pyramidal cell synapses in an experimental MTLE; and (3) to determine whether mGluR II and BK channels can attenuate excessive excitatory transmission at newly "recurrent" mossy fiber-granule cell synapses in a rat model of MTLE. A combination of modern techniques will be used to study presynaptic mechanisms in control versus chronically epileptic rats. Such approaches will include tissue and seizure monitoring, single-cell quantitative real-time PCR, visualized patch-clamp recordings from granule cells and direct visualization of the presynaptic function via the fluorescent styryl dye FM1-43. The long-term goal is to decipher the molecular mechanisms determining "acquired presynaptic channelopathies" and to investigate the consequences of such presynaptic dysfunction in the pathogenesis of MTLE. Data from this proposal may provide the foundation for novel therapeutic interventions for epilepsy.
描述(由申请人提供):癫痫是一组不同的阵发性疾病,与遗传性或后天性离子通道和/或神经递质受体功能障碍(所谓的“通道病”)有关。在人类和实验性内侧颞叶癫痫 (MTLE) 中,海马苔藓纤维经历分子和结构重排。最近的数据显示,癫痫大鼠苔藓纤维中 II 类代谢型谷氨酸受体 (mGluR II) 和大电导 Ca2+ 激活钾通道 (BK 通道) 均出现强烈下调。在正常大脑中,突触前自身受体 mGluR II 与其他离子通道(即 BK 通道)的“反馈”激活会减弱过度的兴奋性传递。因此,mGluR II 和 BK 通道的突触前缺陷可能在癫痫发生中起重要作用。该项目的具体目的是:(1)检验癫痫大鼠苔藓纤维中 mGluR II 和 BK 通道的下调与颗粒细胞中 mRNA 转录物的类似缺陷和剪接变体的异常表达相关的假设; (2) 在实验性 MTLE 中检验癫痫发作引起的 mGluR II 和 BK 通道下调影响突触前功能并加剧苔藓纤维-CA3 锥体细胞突触的兴奋性传递的假设; (3) 确定 mGluR II 和 BK 通道是否可以减弱 MTLE 大鼠模型中新“复发”的苔藓纤维颗粒细胞突触的过度兴奋性传递。将结合现代技术来研究对照大鼠与慢性癫痫大鼠的突触前机制。这些方法将包括组织和癫痫监测、单细胞定量实时 PCR、颗粒细胞的可视化膜片钳记录以及通过荧光苯乙烯基染料 FM1-43 直接可视化突触前功能。长期目标是破译决定“获得性突触前通道病”的分子机制,并研究这种突触前功能障碍在 MTLE 发病机制中的后果。该提案的数据可能为癫痫的新型治疗干预措施提供基础。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emilio Rafael Garrido Sanabria其他文献
Emilio Rafael Garrido Sanabria的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emilio Rafael Garrido Sanabria', 18)}}的其他基金
Targeted immunoliposomes for cell-type specific gene therapy of epilepsy
用于癫痫细胞类型特异性基因治疗的靶向免疫脂质体
- 批准号:
7496563 - 财政年份:2007
- 资助金额:
$ 25.37万 - 项目类别:
Targeted immunoliposomes for cell-type specific gene therapy of epilepsy
用于癫痫细胞类型特异性基因治疗的靶向免疫脂质体
- 批准号:
7386385 - 财政年份:2007
- 资助金额:
$ 25.37万 - 项目类别:
Molecular Determinants of Mossy Fiber Presynaptic Channelopathies in Epilepsy
癫痫苔藓纤维突触前通道病的分子决定因素
- 批准号:
7900125 - 财政年份:2007
- 资助金额:
$ 25.37万 - 项目类别:
Molecular Determinants of Mossy Fiber Presynaptic Channelopathies in Epilepsy
癫痫苔藓纤维突触前通道病的分子决定因素
- 批准号:
7478100 - 财政年份:2007
- 资助金额:
$ 25.37万 - 项目类别:
Molecular Determinants of Mossy Fiber Presynaptic Channelopathies in Epilepsy
癫痫苔藓纤维突触前通道病的分子决定因素
- 批准号:
7902011 - 财政年份:2007
- 资助金额:
$ 25.37万 - 项目类别:
Molecular Determinants of Mossy Fiber Presynaptic Channelopathies in Epilepsy
癫痫苔藓纤维突触前通道病的分子决定因素
- 批准号:
7678463 - 财政年份:2007
- 资助金额:
$ 25.37万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 25.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 25.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 25.37万 - 项目类别: